KORU Medical Systems ROE 2010-2025 | KRMD
Current and historical return on equity (ROE) values for KORU Medical Systems (KRMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| KORU Medical Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $0.02B | -34.29% |
| 2024-12-31 | $-0.01B | $0.02B | -38.36% |
| 2024-09-30 | $-0.01B | $0.02B | -63.16% |
| 2024-06-30 | $-0.01B | $0.02B | -51.76% |
| 2024-03-31 | $-0.01B | $0.02B | -51.06% |
| 2023-12-31 | $-0.01B | $0.02B | -45.71% |
| 2023-09-30 | $-0.01B | $0.03B | -24.14% |
| 2023-06-30 | $-0.01B | $0.03B | -23.14% |
| 2023-03-31 | $-0.01B | $0.03B | -25.40% |
| 2022-12-31 | $-0.01B | $0.03B | -27.48% |
| 2022-09-30 | $-0.01B | $0.03B | -23.36% |
| 2022-06-30 | $-0.01B | $0.03B | -22.54% |
| 2022-03-31 | $-0.01B | $0.04B | -16.44% |
| 2021-12-31 | $0.00B | $0.04B | -10.74% |
| 2021-09-30 | $0.00B | $0.04B | -10.81% |
| 2021-06-30 | $0.00B | $0.04B | -7.95% |
| 2021-03-31 | $0.00B | $0.04B | -7.84% |
| 2020-12-31 | $0.00B | $0.04B | -6.30% |
| 2020-09-30 | $0.00B | $0.04B | -3.92% |
| 2020-06-30 | $0.00B | $0.04B | 0.00% |
| 2020-03-31 | $0.00B | $0.01B | 9.09% |
| 2019-12-31 | $0.00B | $0.01B | 9.76% |
| 2019-09-30 | $0.00B | $0.01B | 10.26% |
| 2019-06-30 | $0.00B | $0.01B | 0.00% |
| 2019-03-31 | $0.00B | $0.01B | 0.00% |
| 2018-12-31 | $0.00B | $0.01B | 0.00% |
| 2018-09-30 | $0.00B | $0.01B | 0.00% |
| 2018-06-30 | $0.00B | $0.01B | 0.00% |
| 2018-03-31 | $0.00B | $0.01B | 0.00% |
| 2017-12-31 | $0.00B | $0.01B | 0.00% |
| 2017-06-30 | $0.00B | $0.01B | 0.00% |
| 2017-03-31 | $0.00B | 0.00% | |
| 2016-11-30 | $0.00B | $0.01B | 0.00% |
| 2016-09-30 | $0.00B | 0.00% | |
| 2016-06-30 | $0.00B | 0.00% | |
| 2016-05-31 | $0.00B | $0.01B | 0.00% |
| 2015-08-31 | $0.00B | $0.01B | 0.00% |
| 2015-05-31 | $0.00B | $0.01B | 0.00% |
| 2014-08-31 | $0.00B | $0.01B | 0.00% |
| 2014-05-31 | $0.00B | $0.01B | 0.00% |
| 2013-08-31 | $0.00B | $0.01B | 0.00% |
| 2013-05-31 | $0.00B | $0.00B | 0.00% |
| 2012-05-31 | $0.00B | $0.00B | 0.00% |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-11-30 | $0.00B | 0.00% | |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.136B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Enovis (ENOV) | United States | $1.765B | 9.84 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |